Alethia Young
Insider
First SEC filing: June 12, 2026 · Latest: June 12, 2026
Insider at
Insider transactions
0 buys (P)
3 sells (S)
Net: $-50,488
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 10, 2026 | PCRX | A | 10,891 | · | · | 10,891 Direct | · | Acquired | (price as of 2026-10-05) |
| June 10, 2026 | PCRX | A | 6,405 | · | · | 17,798 Direct | +56.22% | Acquired | (price as of 2026-10-05) |
| Jan. 5, 2026 | BCYC | S | 2,456 | $6.45 | $15,841 | 88,959 Direct | -2.69% | Disposed | -37.8% (price as of 2026-10-05) |
| Jan. 5, 2026 | BCYC | S 10b5-1 | 1,878 | $6.54 | $12,282 | 87,081 Direct | -2.11% | Disposed | -38.7% (price as of 2026-10-05) |
| Jan. 2, 2026 | BCYC | A | 50,000 | · | · | 94,704 Direct | +111.85% | Acquired | (price as of 2026-10-05) |
| Jan. 2, 2026 | BCYC | S | 3,289 | $6.80 | $22,365 | 91,415 Direct | -3.47% | Disposed | -41.0% (price as of 2026-10-05) |
| Jan. 2, 2026 | BCYC | A | 100,000 | · | · | 100,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 2, 2026 | PTCT | A | 4,000 | · | · | 21,067 Direct | +23.44% | Acquired | (price as of 2026-10-05) |
| Jan. 2, 2026 | PTCT | A | 3,475 | · | · | 3,475 Direct | · | Acquired | (price as of 2026-10-05) |
| Oct. 2, 2025 | BCYC | S 10b5-1 | 217 | $8.40 | $1,823 | 44,969 Direct | -0.48% | Disposed | -52.3% (price as of 2026-10-05) |
| Oct. 2, 2025 | BCYC | S 10b5-1 | 265 | $8.60 | $2,279 | 44,704 Direct | -0.59% | Disposed | -53.4% (price as of 2026-10-05) |
| July 2, 2025 | BCYC | S | 204 | $7.09 | $1,446 | 45,186 Direct | -0.45% | Disposed | -43.4% (price as of 2026-10-05) |
| June 11, 2025 | PCRX | A | 6,163 | · | · | 11,393 Direct | +117.84% | Acquired | (price as of 2026-10-05) |
| June 11, 2025 | PCRX | A | 11,279 | · | · | 11,279 Direct | · | Acquired | (price as of 2026-10-05) |
| April 2, 2025 | BCYC | S | 215 | $8.02 | $1,724 | 45,390 Direct | -0.47% | Disposed | -50.0% (price as of 2026-10-05) |
| Jan. 3, 2025 | PTCT | A | 4,000 | · | · | 17,067 Direct | +30.61% | Acquired | (price as of 2026-10-05) |
| Jan. 3, 2025 | PTCT | A | 8,800 | · | · | 8,800 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 2, 2025 | BCYC | A | 35,000 | · | · | 47,000 Direct | +291.67% | Acquired | (price as of 2026-10-05) |
| Jan. 2, 2025 | BCYC | S | 1,395 | $14.09 | $19,656 | 45,605 Direct | -2.97% | Disposed | -71.5% (price as of 2026-10-05) |
| Jan. 2, 2025 | BCYC | A | 87,000 | · | · | 87,000 Direct | · | Acquired | (price as of 2026-10-05) |
| June 12, 2024 | PCRX | A | 5,230 | · | · | 5,230 Direct | · | Acquired | (price as of 2026-10-05) |
| June 12, 2024 | PCRX | A | 12,179 | · | · | 12,179 Direct | · | Acquired | (price as of 2026-10-05) |
| Feb. 15, 2024 | PTCT | A | 4,000 | · | · | 13,067 Direct | +44.12% | Acquired | (price as of 2026-10-05) |
| Feb. 15, 2024 | PTCT | A | 10,000 | · | · | 10,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 2, 2024 | BCYC | A | 24,000 | · | · | 24,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 2, 2024 | BCYC | A | 12,000 | · | · | 12,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Oct. 6, 2023 | PCRX | A | 30,967 | · | · | 30,967 Direct | · | Acquired | (price as of 2026-10-05) |
| Sept. 6, 2023 | PTCT | M | 7,000 | $27.85 | $194,950 | 16,067 Direct | +77.20% | Acquired | 128.5% (price as of 2026-10-05) |
| Sept. 6, 2023 | PTCT | S | 7,000 | $39.90 | $279,300 | 9,067 Direct | -43.57% | Disposed | 59.5% (price as of 2026-10-05) |
| Sept. 6, 2023 | PTCT | M | 4,666 | $27.85 | $129,948 | 13,733 Direct | +51.46% | Acquired | 128.5% (price as of 2026-10-05) |
| Sept. 6, 2023 | PTCT | S | 4,666 | $39.79 | $185,660 | 9,067 Direct | -33.98% | Disposed | 60.0% (price as of 2026-10-05) |
| Sept. 6, 2023 | PTCT | M | 7,000 | $27.85 | $194,950 | 0 Direct | -100.00% | Disposed | 128.5% (price as of 2026-10-05) |
| Sept. 6, 2023 | PTCT | M | 4,666 | $27.85 | $129,948 | 7,334 Direct | -38.88% | Disposed | 128.5% (price as of 2026-10-05) |
| July 17, 2023 | BCYC | A | 120,000 | · | · | 120,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Feb. 21, 2023 | LENZ | A | 220,000 | · | · | 220,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 5, 2023 | PTCT | A | 4,000 | · | · | 9,067 Direct | +78.94% | Acquired | (price as of 2026-10-05) |
| Jan. 5, 2023 | PTCT | A | 10,000 | · | · | 10,000 Direct | · | Acquired | (price as of 2026-10-05) |
| June 9, 2022 | PTCT | A | 3,200 | · | · | 3,200 Direct | · | Acquired | (price as of 2026-10-05) |
| June 9, 2022 | PTCT | A | 1,867 | · | · | 5,067 Direct | +58.34% | Acquired | (price as of 2026-10-05) |
| June 9, 2022 | PTCT | A | 12,000 | · | · | 12,000 Direct | · | Acquired | (price as of 2026-10-05) |
| June 9, 2022 | PTCT | A | 7,000 | · | · | 7,000 Direct | · | Acquired | (price as of 2026-10-05) |
| April 1, 2022 | LENZ | A | 350,000 | · | · | 350,000 Direct | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 10, 2026 | PCRX | Stock Option (Right to Buy) | Common Stock | $23.42 | June 10, 2036 | 10,891 | Acquired |
| Jan. 2, 2026 | BCYC | Employee Stock Option (right to buy) | Ordinary Shares | $7.08 | Jan. 2, 2036 | 100,000 | Acquired |
| Jan. 2, 2026 | PTCT | Stock Option (Right to Buy) | Common Stock | $76.74 | Jan. 1, 2036 | 3,475 | Acquired |
| June 11, 2025 | PCRX | Stock Option (Right to Buy) | Common Stock | $24.34 | June 11, 2035 | 11,279 | Acquired |
| Jan. 3, 2025 | PTCT | Stock Option (Right to Buy) | Common Stock | $46.54 | Jan. 2, 2035 | 8,800 | Acquired |
| Jan. 2, 2025 | BCYC | Employee Stock Option (right to buy) | Ordinary Shares | $14.00 | Jan. 2, 2035 | 87,000 | Acquired |
| June 12, 2024 | PCRX | Stock Option (Right to Buy) | Common Stock | $28.68 | June 12, 2034 | 12,179 | Acquired |
| Feb. 15, 2024 | PTCT | Stock Option (Right to Buy) | Common Stock | $25.69 | Feb. 14, 2034 | 10,000 | Acquired |
| Jan. 2, 2024 | BCYC | Employee Stock Option (right to buy) | Ordinary Shares | $18.08 | Jan. 2, 2034 | 24,000 | Acquired |
| Oct. 6, 2023 | PCRX | Stock Option (Right to Buy) | Common Stock | $29.80 | Oct. 6, 2033 | 30,967 | Acquired |
| Sept. 6, 2023 | PTCT | Stock Option (Right to Buy) | Common Stock | $27.85 | June 8, 2032 | 7,000 | Disposed |
| Sept. 6, 2023 | PTCT | Stock Option (Right to Buy) | Common Stock | $27.85 | June 8, 2032 | 4,666 | Disposed |
| July 17, 2023 | BCYC | Employee Share Option (Right to Buy) | Ordinary Shares | $26.21 | July 17, 2033 | 120,000 | Acquired |
| Feb. 21, 2023 | LENZ | Stock Option (right to buy) | Common Stock | $2.18 | Feb. 20, 2033 | 220,000 | Acquired |
| Jan. 5, 2023 | PTCT | Stock Option (Right to Buy) | Common Stock | $39.42 | Jan. 4, 2033 | 10,000 | Acquired |
| June 9, 2022 | PTCT | Stock Option (Right to Buy) | Common Stock | $27.85 | June 8, 2032 | 12,000 | Acquired |
| June 9, 2022 | PTCT | Stock Option (Right to Buy) | Common Stock | $27.85 | June 8, 2032 | 7,000 | Acquired |
| April 1, 2022 | LENZ | Stock Option (right to buy) | Common Stock | $5.23 | March 31, 2032 | 350,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2022 | $337,500 | $170,000 | · | $1,212,715 | $115,274 | · | $151,350 | $1,835,489 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.